Brief: Somnomed Keeps FY24 Guidance Unchanged

SomnoMed

30/01/2024 01:00

Jan 30 (Reuters) - Somnomed Ltd  SOM.AX :
    * FY24 GUIDANCE REMAINS UNCHANGED
    * Q2 FY24 REVENUE OF A$23.7 MILLION

Source text for Eikon:  ID:nASX1NZwZ6 
Further company coverage:  SOM.AX 

 ((Reuters.Briefs@thomsonreuters.com;))